ANNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Annexon, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$4.01+0.60 (+17.60%)
Close on Oct 19, 2026
- Market cap
- $806.02M
- P/E (TTM)
- –
- Dividend yield
- 0.00%